IRTC · Irhythm Holdings, Inc. - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $199.39M | - | $192.88M | $186.69M | $158.68M | - | $147.54M | $148.05M | $131.93M | - |
| Cost of Revenue | $58.04M | - | $55.76M | $53.83M | $49.46M | - | $46.06M | $44.58M | $44.41M | - |
| Gross Profit | $141.35M | - | $137.12M | $132.86M | $109.22M | - | $101.48M | $103.47M | $87.52M | - |
| R&D | $21.36M | - | $21.03M | $21.01M | $16.99M | - | $16.31M | $19.69M | $16.99M | - |
| SG&A | $135.88M | - | $124.22M | $126.38M | $119.96M | - | $103.38M | $106.76M | $108.66M | - |
| Total Operating Expenses | $157.54M | - | $145.55M | $151.56M | $141.77M | - | $151.78M | $126.45M | $125.65M | - |
| D&A | $5.00M | - | $5.20M | $5.10M | $5.20M | - | $5.10M | $5.20M | $5.10M | - |
| Operating Income | ($16.18M) | - | ($8.43M) | ($18.71M) | ($32.56M) | - | ($50.30M) | ($22.98M) | ($38.14M) | - |
| Interest Expense | $3.29M | - | $3.28M | $3.28M | $3.27M | - | $3.27M | $0 | $2.86M | - |
| Income Tax | $500.0K | - | $24.0K | ($183.0K) | $665.0K | - | $188.0K | $194.0K | $32.0K | - |
| Net Income | ($13.93M) | - | ($5.21M) | ($14.22M) | ($30.70M) | - | ($46.18M) | ($20.11M) | ($45.67M) | - |
| EPS - Basic | ($0.43) | - | ($0.16) | ($0.44) | ($0.97) | - | ($1.48) | ($0.65) | ($1.47) | - |
| EPS - Diluted | ($0.43) | - | ($0.16) | ($0.44) | ($0.97) | - | ($1.48) | ($0.65) | ($1.47) | - |
Balance Sheet
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $240.15M | $236.01M | $255.60M | $309.11M | $375.28M | $419.60M | $519.53M | $550.55M | $520.42M | $36.17M |
| Accounts Receivable | $80.86M | $75.71M | $76.16M | $82.15M | $80.64M | $79.94M | $77.43M | $85.51M | $89.71M | $61.48M |
| Inventory | $23.80M | $21.63M | $19.56M | $18.40M | $14.34M | $14.04M | $15.03M | $15.43M | $14.87M | $13.97M |
| Accounts Payable | $8.56M | $2.26M | $8.28M | $12.78M | $11.95M | $7.22M | $7.59M | $13.43M | $8.44M | $5.54M |
| Current Assets | $680.56M | $702.76M | $680.03M | $663.92M | $636.01M | $645.82M | $627.91M | $677.51M | $687.46M | $230.81M |
| Total Assets | $1.01B | $1.02B | $995.21M | $964.03M | $926.10M | $931.45M | $909.69M | $919.18M | $909.75M | $433.14M |
| Current Liabilities | $131.75M | $151.89M | $146.91M | $132.21M | $111.34M | $110.92M | $100.10M | $97.89M | $96.84M | $107.37M |
| Long-term Debt | - | - | - | - | - | - | - | - | - | $34.95M |
| Total Liabilities | $845.15M | $867.30M | $873.32M | $860.37M | $839.43M | $840.54M | $837.92M | $820.00M | $819.47M | $223.05M |
| Stockholders' Equity | $161.21M | $152.75M | $121.89M | $103.66M | $86.67M | $90.91M | $71.77M | $99.19M | $90.29M | $210.10M |
| Retained Earnings | ($817.38M) | ($803.45M) | ($809.02M) | ($803.81M) | ($789.60M) | ($758.89M) | ($757.56M) | ($711.38M) | ($691.27M) | ($645.61M) |
Cash Flow
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ($26.17M) | - | - | - | ($7.89M) | - | - | - | ($52.03M) | - |
| Investing Cash Flow | $30.21M | - | - | - | ($38.14M) | - | - | - | $40.00M | - |
| Financing Cash Flow | $149.0K | - | - | - | $1.73M | - | - | - | $504.64M | - |
| CapEx | $6.91M | - | - | - | $9.42M | - | - | - | $9.78M | - |
| Free Cash Flow | ($33.08M) | - | - | - | ($17.31M) | - | - | - | ($61.80M) | - |
Ratios
| Metric | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||
| Gross margin | 70.9% | - | 71.1% | 71.2% | 68.8% | - | 68.8% | 69.9% | 66.3% | - |
| Operating margin | -8.1% | - | -4.4% | -10.0% | -20.5% | - | -34.1% | -15.5% | -28.9% | - |
| EBITDA margin | -5.6% | - | -1.7% | -7.3% | -17.2% | - | -30.6% | -12.0% | -25.0% | - |
| Net margin | -7.0% | - | -2.7% | -7.6% | -19.3% | - | -31.3% | -13.6% | -34.6% | - |
| Free cash flow margin | -16.6% | - | - | - | -10.9% | - | - | - | -46.8% | - |
| FCF / Net income | 2.37 | - | - | - | 0.56 | - | - | - | 1.35 | - |
| R&D / Revenue | 10.7% | - | 10.9% | 11.3% | 10.7% | - | 11.1% | 13.3% | 12.9% | - |
| SG&A / Revenue | 68.1% | - | 64.4% | 67.7% | 75.6% | - | 70.1% | 72.1% | 82.4% | - |
| Effective tax rate | - | - | - | - | - | - | - | - | - | - |
| Return on assets | -1.4% | - | -0.5% | -1.5% | -3.3% | - | -5.1% | -2.2% | -5.0% | - |
| Return on equity | -8.6% | - | -4.3% | -13.7% | -35.4% | - | -64.4% | -20.3% | -50.6% | - |
| Return on invested capital | - | - | - | - | - | - | - | - | - | - |
| Liquidity | ||||||||||
| Current ratio | 5.17 | 4.63 | 4.63 | 5.02 | 5.71 | 5.82 | 6.27 | 6.92 | 7.10 | 2.15 |
| Quick ratio | 4.98 | 4.48 | 4.50 | 4.88 | 5.58 | 5.70 | 6.12 | 6.76 | 6.95 | 2.02 |
| Cash ratio | 1.82 | 1.55 | 1.74 | 2.34 | 3.37 | 3.78 | 5.19 | 5.62 | 5.37 | 0.34 |
| Leverage | ||||||||||
| Debt / Equity | - | - | - | - | - | - | - | - | - | 0.17 |
| Debt / Assets | - | - | - | - | - | - | - | - | - | 0.08 |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Interest coverage | -4.9x | - | -2.6x | -5.7x | -9.9x | - | -15.4x | - | -13.3x | - |
| Equity multiplier | 6.24 | 6.68 | 8.16 | 9.30 | 10.69 | 10.25 | 12.68 | 9.27 | 10.08 | 2.06 |
| Liabilities / Assets | 0.84 | 0.85 | 0.88 | 0.89 | 0.91 | 0.90 | 0.92 | 0.89 | 0.90 | 0.51 |
| Efficiency | ||||||||||
| Asset turnover | 0.20 | - | 0.19 | 0.19 | 0.17 | - | 0.16 | 0.16 | 0.15 | - |
| Inventory turnover | 2.44 | - | 2.85 | 2.93 | 3.45 | - | 3.06 | 2.89 | 2.99 | - |
| Days sales outstanding | 148d | - | 144d | 161d | 185d | - | 192d | 211d | 248d | - |
| Days inventory outstanding | 150d | - | 128d | 125d | 106d | - | 119d | 126d | 122d | - |
| Days payable outstanding | 54d | - | 54d | 87d | 88d | - | 60d | 110d | 69d | - |
| Cash conversion cycle | 244d | - | 218d | 199d | 203d | - | 250d | 227d | 301d | - |
| Valuation | ||||||||||
| P / E | - | - | - | - | - | - | - | - | - | - |
| P / B | 23.8x | - | 45.4x | 47.5x | 38.2x | - | 32.3x | 33.8x | 39.9x | - |
| P / S | 19.2x | - | 28.7x | 26.4x | 20.8x | - | 15.7x | 22.6x | 27.3x | - |
| EV / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Growth | ||||||||||
| Revenue growth (YoY) | 25.7% | - | 30.7% | 26.1% | 20.3% | - | 18.4% | 19.3% | 18.4% | - |
| Revenue CAGR (3y) | 21.4% | - | 22.9% | 22.3% | 19.8% | - | 20.0% | 22.1% | 21.1% | - |
| Revenue CAGR (5y) | 21.8% | - | 21.8% | 29.7% | 20.1% | - | 22.0% | 22.7% | 22.8% | - |
| Gross profit growth (YoY) | 29.4% | - | 35.1% | 28.4% | 24.8% | - | 23.0% | 20.0% | 15.6% | - |
| Operating income growth (YoY) | 50.3% | - | 83.2% | 18.6% | 14.6% | - | -82.2% | -21.8% | 3.5% | - |
| Net income growth (YoY) | 54.6% | - | 88.7% | 29.3% | 32.8% | - | -70.3% | -8.8% | -16.8% | - |
| EPS growth (YoY) | 55.7% | - | 89.2% | 32.3% | 34.0% | - | -66.3% | -6.6% | -14.0% | - |
| EPS CAGR (3y) | - | - | - | - | - | - | - | - | - | - |
| EPS CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| FCF growth (YoY) | -91.1% | - | - | - | 72.0% | - | - | - | -57.8% | - |
| FCF CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Book value growth (YoY) | 86.0% | 68.0% | 69.8% | 4.5% | -4.0% | -56.7% | -67.3% | -55.7% | -59.3% | -12.4% |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2025-12-31.
Product / service
$747.14M totalCommercial Payors$392.23M · 52.5%
Centers For Medicare And Medicaid$179.35M · 24.0%
Healthcare Institutions$125.61M · 16.8%
Non Contracted Third Party Payors$49.94M · 6.7%
Peer comparison
Same SIC group: Surgical & Medical Instruments & Apparatus
Comparing iRhythm Holdings against the 5 most active filers in the same SIC group.